Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), bought 320,628 shares at $31.04 ($10.0M) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal purchase ($10.0M) by Chief Executive Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.04 | 102,821 | $3.2M | 31.9% |
| 2 | $31.04 | 102,821 | $3.2M | 31.9% |
| 3 | $31.53 | 57,493 | $1.8M | 18.1% |
| 4 | $31.53 | 57,493 | $1.8M | 18.1% |
| Total | $31.22 avg | 320,628 | $10.0M | 100% |
| Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |
| MRNA | SELL | 2023-06-16 | $20.4M | — | Filing → |